Fixed-time treatment of elderly patients with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) using hypomethylating agents and venetoclax – a case series

Abstract Standard therapy for elderly patients with acute myeloid leukemia (AML) consists of hypomethylating agents (HMAs) combined with venetoclax (VEN), administered long term until disease progression. However, several retrospective studies have shown that patients in complete remission (CR) who...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Albrecht Lindemann, Gerhard Göckel, Guillermo Garcia-Pardillos
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Springer 2026-05-01
Edice:	Annals of Hematology
Témata:	AML MDS Hypomethylating agents Venetoclax
On-line přístup:	https://doi.org/10.1007/s00277-026-07076-z
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!